Compare NOCIL with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -5.87% of over the last 5 years
With a fall in Net Sales of -4.66%, the company declared Very Negative results in Sep 25
With ROE of 3.6, it has a Very Expensive valuation with a 1.3 Price to Book Value
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 2,279 Cr (Small Cap)
37.00
39
1.50%
-0.16
3.56%
1.26
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Jul-30-2025
Risk Adjusted Returns v/s 
Returns Beta
News

NOCIL Ltd Technical Momentum Shifts Amid Bearish Sentiment
NOCIL Ltd, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals. Despite a recent downgrade to a Strong Sell rating by MarketsMOJO, the stock shows mixed technical indicators that suggest cautious investor sentiment amid ongoing market challenges.
Read full news article
NOCIL Ltd is Rated Strong Sell
NOCIL Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 02 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Nocil Ltd. Stock Hits 52-Week Low Amidst Continued Downtrend
Nocil Ltd., a key player in the specialty chemicals sector, recorded a new 52-week low of Rs.125.95 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The stock has now fallen for three consecutive days, accumulating a loss of 6.76% during this period, reflecting ongoing pressures on the company’s financial performance and market valuation.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30-Jan-2026 | Source : BSEIntimation of Conference Call under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Board Meeting Intimation for Considering And Approving Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2025.
19-Jan-2026 | Source : BSENOCIL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Board Meeting Intimation for considering and approving Un-audited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025.
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
13-Jan-2026 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on January 13 2026 for Mafatlal Industries Ltd
Corporate Actions 
11 Feb 2026
NOCIL Ltd has declared 20% dividend, ex-date: 30 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
18.6633
Held by 9 Schemes (5.68%)
Held by 60 FIIs (4.47%)
Hrishikesh Arvind Mafatlal(as A Trustee Of Gurukripa Trust) (18.16%)
Icici Prudential Retirement Fund-pure Equity Plan (3.56%)
45.19%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -4.66% vs -1.02% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -29.78% vs -16.98% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -10.63% vs -1.70% in Sep 2024
Growth in half year ended Sep 2025 is -57.54% vs 12.58% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -3.23% vs -11.09% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -10.24% vs -24.31% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -3.60% vs -10.63% in Mar 2024
YoY Growth in year ended Mar 2025 is -22.66% vs -10.83% in Mar 2024






